CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer
出版年份 2018 全文链接
标题
CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer
作者
关键词
-
出版物
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 24, Issue 42, Pages 4738-4749
出版商
Baishideng Publishing Group Inc.
发表日期
2018-11-13
DOI
10.3748/wjg.v24.i42.4738
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Gut microbiota modulate T cell trafficking into human colorectal cancer
- (2018) Eleonora Cremonesi et al. GUT
- International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
- (2018) Franck Pagès et al. LANCET
- CXCR5 + CD8 + T cells infiltrate the colorectal tumors and nearby lymph nodes, and are associated with enhanced IgG response in B cells
- (2017) Junjie Xing et al. EXPERIMENTAL CELL RESEARCH
- Loss of dual-specificity phosphatase-2 promotes angiogenesis and metastasis via up-regulation of interleukin-8 in colon cancer
- (2017) Shih-Chieh Lin et al. JOURNAL OF PATHOLOGY
- Targeting CXCR4-dependent immunosuppressive Ly6Clowmonocytes improves antiangiogenic therapy in colorectal cancer
- (2017) Keehoon Jung et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Circulating inflammatory factors associated with worse long-term prognosis in colorectal cancer
- (2017) Renate S Olsen et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Interferon-inducible CXC-chemokines are crucial immune modulators and survival predictors in colorectal cancer
- (2017) Larissa Kistner et al. Oncotarget
- IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients
- (2017) Mariantonietta Di Salvatore et al. Oncotarget
- ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
- (2016) E. Van Cutsem et al. ANNALS OF ONCOLOGY
- The chemokine CXCL9 expression is associated with better prognosis for colorectal carcinoma patients
- (2016) Zhenqian Wu et al. BIOMEDICINE & PHARMACOTHERAPY
- Ectopic expression of the chemokine CXCL17 in colon cancer cells
- (2016) Lina Ohlsson et al. BRITISH JOURNAL OF CANCER
- Epithelial Hypoxia-Inducible Factor 2α Facilitates the Progression of Colon Tumors through Recruiting Neutrophils
- (2016) Daniel Triner et al. MOLECULAR AND CELLULAR BIOLOGY
- Colorectal Cancer on the Decline — Why Screening Can’t Explain It All
- (2016) H. Gilbert Welch et al. NEW ENGLAND JOURNAL OF MEDICINE
- Toll-like receptor-5 agonist, entolimod, suppresses metastasis and induces immunity by stimulating an NK-dendritic-CD8+T-cell axis
- (2016) Craig M. Brackett et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- LPS-induced CXCR4-dependent migratory properties and a mesenchymal-like phenotype of colorectal cancer cells
- (2016) Wen-Ting Liu et al. Cell Adhesion & Migration
- Co-expression of Lgr5 and CXCR4 characterizes cancer stem-like cells of colorectal cancer
- (2016) Weidong Wu et al. Oncotarget
- Neuroendocrine-like cells -derived CXCL10 and CXCL11 induce the infiltration of tumor-associated macrophage leading to the poor prognosis of colorectal cancer
- (2016) Yu-Jie Zeng et al. Oncotarget
- Inhibition of Growth and Metastasis of Colon Cancer by Delivering 5-Fluorouracil-loaded Pluronic P85 Copolymer Micelles
- (2016) Pengxi Zhu et al. Scientific Reports
- Curcumin mediates oxaliplatin-acquired resistance reversion in colorectal cancer cell lines through modulation of CXC-Chemokine/NF-κB signalling pathway
- (2016) Vicenç Ruiz de Porras et al. Scientific Reports
- The Association of CXC Receptor 4 Mediated Signaling Pathway with Oxaliplatin-Resistant Human Colorectal Cancer Cells
- (2016) Wen-Shih Huang et al. PLoS One
- Chemotherapeutic agents attenuate CXCL12-mediated migration of colon cancer cells by selecting for CXCR4-negative cells and increasing peptidase CD26
- (2015) Murray J. Cutler et al. BMC CANCER
- CXCL4 mediates tumor regrowth after chemotherapy by suppression of antitumor immunity
- (2015) Yang Zhang et al. CANCER BIOLOGY & THERAPY
- STAT3 Inhibition Enhances the Therapeutic Efficacy of Immunogenic Chemotherapy by Stimulating Type 1 Interferon Production by Cancer Cells
- (2015) Heng Yang et al. CANCER RESEARCH
- Overexpression of chemokine receptor CXCR2 and ligand CXCL7 in liver metastases from colon cancer is correlated to shorter disease-free and overall survival
- (2015) Thibault Desurmont et al. CANCER SCIENCE
- Treg-cell depletion promotes chemokine production and accumulation of CXCR3+conventional T cells in intestinal tumors
- (2015) Paulina Akeus et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The consensus molecular subtypes of colorectal cancer
- (2015) Justin Guinney et al. NATURE MEDICINE
- First-line chemotherapy for mCRC—a review and evidence-based algorithm
- (2015) Chiara Cremolini et al. Nature Reviews Clinical Oncology
- CXCL16 induces angiogenesis in autocrine signaling pathway involving hypoxia-inducible factor 1α in human umbilical vein endothelial cells
- (2015) XIAOWEN YU et al. ONCOLOGY REPORTS
- Identification of Novel Biomarkers for Metastatic Colorectal Cancer Using Angiogenesis-Antibody Array and Intracellular Signaling Array
- (2015) Seyung Chung et al. PLoS One
- An integrative approach for the identification of prognostic and predictive biomarkers in rectal cancer
- (2015) Marco Agostini et al. Oncotarget
- Active secretion of CXCL10 and CCL5 from colorectal cancer microenvironments associates with GranzymeB+ CD8+ T-cell infiltration
- (2015) Timothy J. Zumwalt et al. Oncotarget
- CXCL16 suppresses liver metastasis of colorectal cancer by promoting TNF-α-induced apoptosis by tumor-associated macrophages
- (2015) Ji-Ye Kee et al. BMC CANCER
- Lymph Node Stromal Cells Enhance Drug-Resistant Colon Cancer Cell Tumor Formation through SDF-1α/CXCR4 Paracrine Signaling
- (2015) David A. Margolin et al. NEOPLASIA
- Chemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity
- (2014) Jason W. Griffith et al. Annual Review of Immunology
- Cancer treatment and survivorship statistics, 2014
- (2014) Carol E. DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Interaction of the chemokines I-TAC (CXCL11) and SDF-1 (CXCL12) in the regulation of tumor angiogenesis of colorectal cancer
- (2014) Kathrin Rupertus et al. CLINICAL & EXPERIMENTAL METASTASIS
- The influence of lentivirus-mediated CXCR4 RNA interference on hepatic metastasis of colorectal cancer
- (2014) TIAN-BAO WANG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Cutting Edge: GPR35/CXCR8 Is the Receptor of the Mucosal Chemokine CXCL17
- (2014) José L. Maravillas-Montero et al. JOURNAL OF IMMUNOLOGY
- CXCL13-CXCR5 axis promotes the growth and invasion of colon cancer cells via PI3K/AKT pathway
- (2014) Zhenyu Zhu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Hypoxia differentially regulated CXCR4 and CXCR7 signaling in colon cancer
- (2014) Benoît Romain et al. Molecular Cancer
- New nomenclature for atypical chemokine receptors
- (2014) Françoise Bachelerie et al. NATURE IMMUNOLOGY
- CXCL10 mRNA expression predicts response to neoadjuvant chemoradiotherapy in rectal cancer patients
- (2014) Cong Li et al. TUMOR BIOLOGY
- The Disparate Twins: A Comparative Study of CXCR4 and CXCR7 in SDF-1α–Induced Gene Expression, Invasion and Chemosensitivity of Colon Cancer
- (2013) Doreen Heckmann et al. CLINICAL CANCER RESEARCH
- Endocytic trafficking of chemokine receptors
- (2013) Adriano Marchese CURRENT OPINION IN CELL BIOLOGY
- Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
- (2013) Gabriela Bindea et al. IMMUNITY
- CXCR2 inhibition enhances sulindac-mediated suppression of colon cancer development
- (2013) Yong Suk Lee et al. INTERNATIONAL JOURNAL OF CANCER
- Molecular Profiling of Multiple Human Cancers Defines an Inflammatory Cancer-Associated Molecular Pattern and Uncovers KPNA2 as a Uniform Poor Prognostic Cancer Marker
- (2013) Saleh M. Rachidi et al. PLoS One
- CXCL17, an orphan chemokine, acts as a novel angiogenic and anti-inflammatory factor
- (2012) Wei-Yu Lee et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- The prognostic significance of chemokine receptor CXCR3 expression in colorectal carcinoma
- (2012) Zhenqian Wu et al. BIOMEDICINE & PHARMACOTHERAPY
- Identification of predictive circulating biomarkers of bevacizumab-containing regimen efficacy in pre-treated metastatic colorectal cancer patients
- (2012) A Abajo et al. BRITISH JOURNAL OF CANCER
- A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis
- (2012) Swarnali Acharyya et al. CELL
- ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis
- (2012) Trude H Ågesen et al. GUT
- The role of CXCR3 and CXCR4 in colorectal cancer metastasis
- (2012) Teppei Murakami et al. INTERNATIONAL JOURNAL OF CANCER
- Intracellular CXCR4+ cell targeting with T22-empowered protein-only nanoparticles
- (2012) Antonio Villaverde et al. International Journal of Nanomedicine
- Visfatin induces stromal cell-derived factor-1 expression by β1 integrin signaling in colorectal cancer cells
- (2012) Wen-Shih Huang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis
- (2012) Thomas Jamieson et al. JOURNAL OF CLINICAL INVESTIGATION
- The CXCR2 Antagonist, SCH-527123, Shows Antitumor Activity and Sensitizes Cells to Oxaliplatin in Preclinical Colon Cancer Models
- (2012) Yan Ning et al. MOLECULAR CANCER THERAPEUTICS
- Chemokine CXCL16 suppresses liver metastasis of colorectal cancer via augmentation of tumor-infiltrating natural killer T cells in a murine model
- (2012) JI-YE KEE et al. ONCOLOGY REPORTS
- CXCL17 Expression by Tumor Cells Recruits CD11b+Gr1highF4/80− Cells and Promotes Tumor Progression
- (2012) Aya Matsui et al. PLoS One
- Synergistic Antitumor Effects of Endostar in Combination with Oxaliplatin via Inhibition of HIF and CXCR4 in the Colorectal Cell Line SW1116
- (2012) Fengyan Jin et al. PLoS One
- Soluble CXCL16 in Preoperative Serum is a Novel Prognostic Marker and Predicts Recurrence of Liver Metastases in Colorectal Cancer Patients
- (2011) Kohei Matsushita et al. ANNALS OF SURGICAL ONCOLOGY
- CXCR4 Expression Predicts Patient Outcome and Recurrence Patterns after Hepatic Resection for Colorectal Liver Metastases
- (2011) Adam C. Yopp et al. ANNALS OF SURGICAL ONCOLOGY
- The role of CXC chemokines in the transition of chronic inflammation to esophageal and gastric cancer
- (2011) Verbeke Hannelien et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Pharmacogenetic Angiogenesis Profiling for First-line Bevacizumab plus Oxaliplatin-Based Chemotherapy in Patients with Metastatic Colorectal Cancer
- (2011) A. Gerger et al. CLINICAL CANCER RESEARCH
- Down-regulation of CXCL1 inhibits tumor growth in colorectal liver metastasis
- (2011) Obul R. Bandapalli et al. CYTOKINE
- CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer
- (2011) Mikio Kawamura et al. EUROPEAN JOURNAL OF CANCER
- Role of Endothelial Chemokines and Their Receptors during Inflammation
- (2011) Cecilia L. Speyer et al. JOURNAL OF INVESTIGATIVE SURGERY
- Small molecule antagonists for CXCR2 and CXCR1 inhibit human colon cancer liver metastases
- (2010) Michelle L. Varney et al. CANCER LETTERS
- Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models
- (2010) Yan Ning et al. INTERNATIONAL JOURNAL OF CANCER
- Teaching old receptors new tricks: biasing seven-transmembrane receptors
- (2010) Sudarshan Rajagopal et al. NATURE REVIEWS DRUG DISCOVERY
- Overexpression of VCC-1 gene in human hepatocellular carcinoma cells promotes cell proliferation and invasion
- (2009) X. Mu et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- The role of CXCL16 and its processing metalloproteinases ADAM10 and ADAM17 in the proliferation and migration of human mesangial cells
- (2008) Anja Schramme et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The role of CXC chemokines and their receptors in cancer
- (2008) Jo Vandercappellen et al. CANCER LETTERS
- TSU68 Prevents Liver Metastasis of Colon Cancer Xenografts by Modulating the Premetastatic Niche
- (2008) M. Yamamoto et al. CANCER RESEARCH
- Chemotherapy-Induced CXC-Chemokine/CXC-Chemokine Receptor Signaling in Metastatic Prostate Cancer Cells Confers Resistance to Oxaliplatin through Potentiation of Nuclear Factor- B Transcription and Evasion of Apoptosis
- (2008) C. Wilson et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now